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ABSTRACT: Using the components of a particularly 
well-studied plant virus, cowpea chlorotic mottle 
virus (CCMV), we demonstrate the synthesis of vi-
rus-like particles (VLPs) with one end of the pack-
aged RNA extending out of the capsid and into the 
surrounding solution. This construct breaks the oth-
erwise perfect symmetry of the capsid and provides a 
straightforward route for monofunctionalizing VLPs 
using the principles of DNA nanotechnology. It also 
allows physical manipulation of the packaged RNA, a 
previously inaccessible part of the viral architecture. 
Our synthesis does not involve covalent chemistry of 
any kind; rather, we trigger capsid assembly on a 
scaffold of viral RNA that is hybridized at one end to 
a complementary DNA strand. Interaction of CCMV 
capsid protein with this RNA-DNA template leads to 
selective packaging of the RNA portion into a well-
formed capsid, but leaves the hybridized portion 
poking out of the capsid through a small hole. We 
show that the nucleic acid protruding from the cap-
sid is capable of binding free DNA strands and DNA-
functionalized colloidal particles. Separately, we 
show that the RNA-DNA scaffold can be used to nu-
cleate virus formation on a DNA-functionalized sur-
face. We believe this self-assembly strategy can be 
adapted to viruses other than CCMV. 
 Small RNA viruses consist entirely of ge-
nomic RNA packaged inside a one-molecule-thick 
protective protein capsid (Fig.1). In addition to mak-
ing up a large fraction of the world’s viral pathogens, 
small RNA viruses are helping to define new fields of 
applied science through their use as functional na-
noparticles1. For example, they have been exploited 
as contrast agents for biomedical imaging2–5, as vec-
tors for the delivery of small molecules and genes to 
cells6–11, and as nanoscale building blocks for the 
formation of superstructures with unique material, 
optical and dynamic properties12–17.  
 
 
 
 
Figure 1. The capsid of cowpea chlorotic mottle virus 
(CCMV), like many small RNA viruses, has icosahedral 
symmetry and consists of 180 copies of its capsid pro-
tein. Diameter is 28 nm. Taken from VIPERdb18. 
 Much of the utility of small RNA viruses de-
rives from their symmetric capsids19 which can be 
engineered to display a high density of functional 
moieties. Indeed, an arsenal of functionalization 
strategies20–31 has been developed that combine mo-
lecular biology (cloning) and/or selective covalent 
chemistries to isotropically label the various polyva-
lent surfaces (exterior, interior, and interfacial1) of 
the capsid. However, in situations where a high de-
gree of labeling is not desired, monofunctional parti-
cles that display only a single copy (or a specific lim-
ited arrangement) of a particular functional group 
are needed. Not surprisingly, monofunctional virus 
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particles are difficult to produce32–34 in a controlled 
way due to the inherent symmetry of the capsid and 
its abundance of equivalent binding sites.  
 Lying just beneath the capsid, the viral RNA 
contains a wealth of inequivalent binding sites that 
could in principle be selectively targeted using the 
methods of DNA nanotechnology35–40. Unfortunate-
ly, the capsid is impermeable to these techniques – 
the main evolutionary purpose of the capsid is to 
protect the RNA from unfavorable interactions with 
macromolecules from the outside world. Our work 
bypasses this inaccessibility through the synthesis of 
virus-like particles (VLPs) with a portion of one end 
of the RNA extending outside of the capsid (Fig. 2). 
With the symmetry of the particle broken by the ex-
posed RNA, we generate robust monofunctionaliza-
tion through the conjugation of desired moieties us-
ing only Watson-Crick basepairing.  
 
Figure 2. (A) Schematic illustration of assembly of the 
“cherry bomb”. (B) Positive-stain transmission electron 
micrograph (TEM) of a cherry bomb capsid (dark 
sphere measuring 26 nm) and its RNA-DNA appendage 
(lighter strand extending upward).  
 Our synthesis (Fig. 2A) requires neither ge-
netic modification nor covalent chemistry, but in-
stead relies on the ability of a particularly well-
studied small RNA virus, CCMV, to be disassembled 
and reconstituted by self-assembly in vitro41. Addi-
tionally, we exploit the qualitative structural differ-
ences between single-stranded (ss) and double-
stranded (ds) nucleic acid to reshape the viral RNA 
that templates the assembly.  
Owing to extensive intramolecular base pair-
ing, ss-RNA of the length naturally packaged by 
CCMV (about 3 kb) is a highly branched, flexible, 
compact object that has physical dimensions compa-
rable to the capsid interior42 (22-nm-internal diame-
ter). In contrast, the same length (3 kbp) of ds-DNA 
occupies a much larger volume owing to its increased 
stiffness (~50 nm persistence length) and lack of 
branching. As a result, ds-DNA longer than about 75 
bp cannot be accommodated within the interior vol-
ume of the CCMV capsid and does not function as a 
template for normal capsid assembly43,44. 
 By hybridizing the first 185 bases at the 5’-
end of a 3.2 kb ss-RNA with a complementary ss-
DNA strand, we dramatically stiffen the 5’-end of the 
RNA. [We use the 5’-end of the 3234-base RNA mol-
ecule (“B1”) of the tripartite genome of brome mosaic 
virus (BMV), although either end of any similar-
length sequence will likely do.] Here, the DNA 
strand (see SI) acts as a molecular splint. The result-
ing RNA-DNA hybrid can be expected to behave as a 
compact, flexible, branched 3-kb ss-RNA connected 
to a rigid, linear, 185-base ds-RNA-DNA appendage 
(see 2nd-from-left cartoon in Fig. 2A). The physical 
length of the ds portion is about 50 nm. It is very 
stable (85ºC melting temperature) owing to its per-
fect sequence complementarity.  
The in vitro packaging of this RNA-DNA hy-
brid by CCMV capsid protein (CP), using the same 
protocol developed earlier for pure RNA45–47, results 
in the selective encapsidation of the ss-RNA portion 
and leaves the ds-RNA-DNA appendage poking out 
of the capsid and into solution. We refer to this final 
construct as a “cherry bomb” because of its structural 
resemblance (Fig. 2B, additional images shown in SI, 
Fig. S1) to the well-known explosive firework48. 
 While the structure of the hole that passes 
the ds-RNA-DNA through the capsid is not known, 
previous in vitro packaging studies have shown ss 
and ds nucleic acid traversing the capsids of CCMV 
and the closely related BMV. We previously ob-
served49 that ss-RNA molecules significantly longer 
than wild-type are packaged by multiple CCMV cap-
sids (“multiplets”) that each share a portion of the 
overlong RNA (Fig. 3). And a separate study44 found 
that long ds-DNA is packaged by a contiguous string 
of many BMV capsids if ss-RNA fragments are also 
present. In both cases nucleic acid is shared by con-
nected capsids, passing through one or more holes in 
each capsid that are too small to be seen by negative-
stain TEM. It is likely that the ds-RNA-DNA append-
age of the cherry bomb exits the capsid through a 
similar hole.  
 
Figure 3. Single ss-RNA molecules progressively longer 
than wild-type (3kb) are shared by two or more CCMV 
capsids – multiplets49. Scale bar shows 25 nm. Copy-
right © American Society for Microbiology, [Journal of 
Virology, 86, 2012, 3322, doi:10.1128/JVI.06566-11]. 
doi: 10.1021/jacs.5b03770 
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 To test whether the exposed RNA-DNA ap-
pendage can be used to bind nucleic acids in solu-
tion, we designed the DNA splint with a 3’ poly-A15 
overhang in addition to the 185 bases that comple-
ment the 5’-end of the RNA (see right-most cartoon 
in Fig. 2A). Once formed, cherry bombs were com-
bined with fluorescent (green) ss-poly-T15 DNA 
strands and analyzed by native agarose gel electro-
phoresis (Fig. 4). The cherry bombs and the fluores-
cent poly-T15 co-migrated (Fig. 4, lane 3), confirming 
that the poly-A15 sticky end of the RNA-DNA ap-
pendage binds its complementary strand in solution. 
Control experiments in which already-assembled 
VLPs containing only 3.2 kb RNA (B1) were added to 
the splint DNA and fluorescent poly-T15 showed no 
nonspecific binding (Fig. 4, lane 4).  
 
Figure 4. Native agarose gel electrophoresis shows cher-
ry bombs selectively bind fluorescently labeled poly-T15 
DNA strands (green). Fluorescently labeled RNA shown 
in red. 
 The ability of the cherry bomb to bind a 
functionalized surface was demonstrated by direct 
imaging of a mixture of these capsids with 30-nm 
gold nanoparticles (AuNPs) that had been previously 
decorated with a high density of ss-poly-T25 DNA 
strands50 (Fig. S2). Negative-stain TEM (Fig. 5) shows 
a high concentration of capsids at the AuNP surface, 
and an exceptionally well-stained image reveals the 
RNA-DNA appendage linking the capsids to the gold 
surface (Fig. 5, arrows). Control experiments be-
tween B1 VLPs and functionalized AuNPs showed no 
non-specific binding (Fig. S3).   
 
Figure 5. Cherry bomb capsids bind the surface of 
DNA-functionalized 30-nm AuNPs. A zoomed-in 
transmission electron micrograph resolves the RNA-
DNA duplex (arrows) linking the capsids (light 
spheres) and the AuNPs (dark sphere). Scale bars show 
25 nm.  
 Separately, we tested whether capsids could 
be assembled around RNAs that were already teth-
ered to a functionalized surface (Fig. 6A). Here, the 
hybrid RNA-DNA scaffold was prepared and equili-
brated with 30-nm poly-T25-coated AuNPs at a molar 
ratio of 10:1 (RNA:AuNP). After hybridization of the 
RNA to the AuNPs, CP was added at a mass ratio of 
10:1 (CP:RNA), equilibrated for 5 min on ice, and im-
aged by negative-stain TEM (Fig. 6B). The presence 
of well-defined capsids at the Au particle surface 
demonstrated assembly of cherry bomb capsids 
around the immobilized RNA-DNA. Some aggrega-
tion of CP in the presence of AuNPs was also ob-
served (Fig. S4).  
 
Figure 6. (A) Schematic showing the assembly of VLPs 
on a DNA-functionalized (green strands) surface. (B) 
Electron micrographs of cherry bomb capsids (light 
spheres) grown on 30-nm AuNPs (dark spheres) as 
shown in (A). Scale bar shows 25 nm. 
While several elegant methods have recently 
been described for the monofunctionalization of 
tobacco mosaic virus particles51–53, they most likely 
cannot be applied to other viruses – they require ei-
ther controlled disassembly of one end of the rod-
like capsid or self-assembly of capsids on a substrate-
bound RNA that contains a specific packaging se-
quence. The homogeneous assembly pathway de-
scribed here provides a general strategy for mono-
functionalizing icosahedral particles. Here we note 
that the ability to form cherry bomb structures is 
probably not limited to the plant virus CCMV; mul-
tiplet capsids have been observed in the packaging of 
overlong RNAs by the CP of the bacterial virus fr54 
and of the mammalian virus SV4055, indicating that 
they too have the potential to form cherry bombs.  
doi: 10.1021/jacs.5b03770 
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In addition to offering a single, highly-
specific, binding modality for building functional 
viral-based materials, our method for (i) physically 
binding and manipulating one end of the packaged 
genome and (ii) nucleating capsid assembly at a sur-
face will enable new single-particle measurements 
that might reveal how RNA gets into and out of viral 
capsids during infection. Examples of such meas-
urements include time-resolved studies of capsid 
assembly, and force-pulling experiments56,57 that 
measure the work required to pull viral RNA out of 
its capsid. 
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Capsid protein (CP) was purified from wild-
type cowpea chlorotic mottle virus (CCMV) grown in 
California cowpea plants (Vigna ungiculata cv 
Black Eye) as described by Annamalai and Rao1. 
Briefly, virions were disrupted by 24-h dialysis 
against disassembly buffer (1M CaCl2, 50 mM Tris pH 
7.5, 1 mM EDTA, 1 mM DTT, and 0.5 mM PMSF) at 
4°C. The RNA was pelleted by ultracentrifugation at 
4 x 105 g for 90 min and the CP was extracted from 
the supernatant in separate fractions. Each fraction 
was immediately dialyzed against protein buffer (1M 
NaCl, 20 mM Tris pH = 7.2, 1 mM EDTA, 1 mM DTT, 
and 1 mM PMSF). The protein concentration and its 
purity, with respect to RNA contamination, were 
measured by UV-Vis spectrophotometry – only pro-
tein samples with 280/260 ratios greater than 1.5 
(less than 5% RNA contamination) were used for 
assembly. SDS-PAGE gel electrophoresis and 
MALDI-TOF showed no evidence of cleaved protein.  
Fluorecently labeled brome mosaic virus ge-
nomic RNA1 (B1) was synthesized by in vitro tran-
scription of a linearized DNA template by T7 RNA 
polymerase and fluorecent rUTP-AF488 (Chroma-
Tide® Alexa Fluor® 488-5-UTP; Molecular Probes, 
U.S.A.). A rATP:rGTP:rCTP:rUTP:rUTP-AF488 molar 
ratio of 600:600:600:5.32:1 was used and resulted in a 
density of labeling of 0.5 rUTP-AF488s per RNA. 
After transcription, the template DNA was digested 
by DNase I (New England Biolabs), and the resulting 
fragments removed by washing five times with a 20-
fold excess of TE buffer (10mM Tris pH 7.5, 1 mM 
EDTA) using a 100 kDa MWCO centrifugal filter de-
vice (EMD Milipore) operated at 5,000 g. 
The DNA splint strand was purchased from 
Integrated DNA Technologies. The sequence is 
shown below: 
 
5’-AATCTGCGCAGATAACTGTTGCGCGACCTGA 
TTGTCTACGATGTCTTGGGCACTCTGGCTGGCA 
GCACCCTTCTCAGCAATCAACTTCAGCAAATCG 
ATAGAACTTGACATTTTGTTGGTGAAAAACAAAG 
AACAAGTAGCAGAACCGTGGTCGACAAGGGAT 
TGAACCTCGTTCCGTGGTCTACAAAAAAAAAAA 
AAAA-3’ 
 
This sequence consists of the reverse complement of 
the first 185 bases of the 5’ terminus of B1 RNA fol-
lowed by poly-A15. 
 We did not test whether DNA splints with 
complementary sequences shorter than 185-bases are 
capable of templating the assembly of cherry bombs, 
though we suspect this is the case. Assuming that the 
rise of hybridized ds-RNA-DNA is intermediate be-
tween those of ds-DNA (0.34 nm per bp) and ds-
RNA (0.25nm per bp), the physical length of a 185 bp 
hybrid strand measures about 55 nm, 2-3 times the 
inner diameter (22 nm) of the CCMV capsid. There-
fore, we expect that much shorter DNA splints (as 
short as, say, 80 bases) should lead to hybrid ds-
RNA-DNA portions that are too long to be packaged. 
However, these cherry bombs would have “fuses” 
that extend a shorter distance from the capsid. Al-
ternatively, multiple short DNA splints designed to 
bind adjacent RNA sequences might be used to gen-
erate a more flexible fuse, due to the nicks between 
each pair of neighboring splints. 
doi: 10.1021/jacs.5b03770 
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Fluorescent Poly-T15 was similarly purchased 
with 6-FAM conjugated to the 5’-terminus. 
RNA-DNA hybridization was performed by 
mixing a 1:1 molar ratio of B1 RNA and splint DNA, 
each at 1μM, in hybridization buffer (10mM Tris pH 
7.5, 200 mM NaCl, 1 mM EDTA), heating to 90°C for 
1 min, cooling to 55°C for 3 min, and cooling to 4°C 
indefinitely. 
 
Assembly was carried out as described in our 
earlier packaging studies involving CCMV CP and 
pure RNA2–4. Briefly, the RNA-DNA scaffold (final 
concentration 1nM) was mixed with purified CCMV 
CP in a ratio (wt/wt) of 6:1 in protein buffer and then 
dialyzed overnight at 4 °C against assembly buffer 
(50 mM NaCl, 10 mM KCl, 5 mM MgCl2, 1 mM DTT, 
50 mM Tris-HCl pH 7.2). The samples were then dia-
lyzed against virus suspension buffer (50 mM sodi-
um acetate, 8 mM magnesium acetate pH 4.75) for at 
least 6 h to complete the assembly process. The 
products were then concentrated using a 100 kDa 
MWCO centrifugal filter device (EMD Milipore) op-
erated at 3,000 g. 
The yield of cherry bombs – the fraction of 
RNA-DNA hybrids that are packaged by protein into 
capsids, with the ssDNA end accessible outside – was 
difficult to quantify by direct visualization by TEM 
because of the faint signal from the exposed RNA-
DNA fuse. The majority of the assembly products 
appeared as well-formed capsids, but the number of 
capsids with a clearly visible fuse (Fig. S1) was low. 
However, native agarose gel electrophoresis showed 
that equilibrating roughly equal molar concentra-
tions of cherry bombs and fluorescently labeled 
poly-dT (Fig. 4) resulted in all of the poly-dT signal 
comigrating with the cherry bombs (see lane 3 of Fig. 
4) – suggesting that most of the RNA-DNA hybrids 
were packaged and that the resulting cherry bombs 
had functional fuses. 
30-nm diameter gold nanoparticles (AuNPs) were 
functionalized following the protocol described by 
Hurst, Lytton-Jean, and Mirkin5. Briefly, 20 nmoles 
of 5’ dithiol-terminated Poly-T25 DNA oligos (Inte-
grated DNA Technologies) were incubated with DTT 
(0.1M DTT, 0.18M phosphate buffer, pH 8) for 1 hour 
at room temperature.  The DTT was then removed 
with a Nap-5 column (Sephadex G-25 DNA Grade), 
and the purified oligo concentration was determined 
by UV-visible spectroscopy. 2 nmoles of deprotected, 
thiolated Poly-T25 oligos (final concentration of 1 
μM) were added to 1 ml of 30 nm citrate-stabilized 
gold nanoparticles (Nanopartz Inc., OD=1, 0.05 
mg/ml, final concentration of 300 pM) and the mix-
ture was brought to 0.01M phosphate buffer pH 7, 
0.01% SDS. The reaction was mixed and sonicated 
thoroughly, then incubated on a rotator for 2 hours 
in the dark.  The conjugation mix was incrementally 
introduced to higher salt conditions in the following 
way: 12.5 μL of 2M NaCl was mixed thoroughly into 
the reaction vessel, followed by sonication and a 1 
hour incubation. This procedure was repeated a total 
of 6 times, bringing the final concentration of NaCl 
to 0.1M. After salting, the reaction mix was left on a 
rotator overnight in the dark.  To remove unbound 
DNA oligos, the solution was centrifuged at 10,000 g 
for 20 minutes, the supernatant was removed, and 
the gold nanoparticle pellet was resuspended in 1 ml 
0.01M phosphate buffer pH 8, 0.1M NaCl, 0.01% SDS.  
This was repeated 3 times, and the final pellet resus-
pended in 0.01M phosphate buffer pH 8, 0.1M NaCl.  
The products were imaged by negative-stain TEM 
(Fig. S2), which revealed a faint ring of material sur-
rounding the electron-dense AuNP that most likely 
corresponds to the DNA coat. The number of Poly-
T25 oligos coating the nanoparticles was not quanti-
fied, but oligo-coating was tested qualitatively using 
a salt-stability assay. 
 
 
Figure S1. Positive stain TEM images of cherry bomb 
assembly products that show the ds-RNA-DNA “fuse”. 
doi: 10.1021/jacs.5b03770 
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Figure S2. 30-nm AuNP coated with poly-T25 imaged by 
negative-stain TEM. Scale bar shows 25 nm. 
A control co-assembly reaction involving 
CCMV CP and pure B1 RNA was performed in paral-
lel with the cherry bomb assembly reactions. The 
assembly products of the control reaction were then 
mixed with poly-T25-coated AuNPs, equilibrated for 5 
min on ice, and imaged by negative-stain TEM (Fig. 
S3). The same conditions were used to assess the 
binding of cherry bomb capsids with the poly-T25-
coated AuNPs. The control micrographs revealed no 
evidence of non-specific VLP-AuNP binding.  
 
            
Figure S3. 30-nm AuNPs coated with poly-T25 (dark 
spheres) were incubated with VLPs containing pure B1 
RNA (light spheres) and imaged by negative-stain TEM. 
There is no interaction between VLPs and AuNPs. Scale 
bar shows 25 nm. 
Hybridized RNA-DNA was prepared and 
equilibrated with 30-nm poly-T25-coated AuNPs at a 
molar ratio of 10:1 (RNA:AuNP) for 30 min on ice. 
After hybridization of the RNA to the AuNPs, CP was 
added at a mass ratio of 10:1 (CP:RNA), equilibrated 
for 5 min on ice, and imaged by negative-stain EM 
(Fig. 5B). We used a higher amount of CP (compared 
to the 6-fold mass ratio used to completely package 
unbound RNA3,4) in case a fraction of the CP was 
bound by the excess of poly-T25 DNA oligos coating 
the surface of the AuNPs. Indeed, TEM images show-
ing thickened layers of material coating the AuNP 
surface suggest that CP does bind the poly-T25-
coating (Fig. S4). Earlier assembly studies3 using 
pure RNA showed that CP:RNA mass ratios higher 
than 6:1 can result in aggregation. This phenomenon 
may contribute to the aggregation we see in the 
AuNP-bound assemblies (Fig. S4).  
 
               
Figure S4. VLP assembly around RNA-DNA bound to 
the surface of 30-nm AuNPs coated with poly-T25 
showed significant aggregation. The three types of ag-
gregation seen are (i) an extra layer of material coating 
each AuNP (thick white halos surrounding electron-
dense AuNP found in all images), (ii) extended capsid 
structures (upper-left image), and (iii) amorphous ag-
gregation (upper-right and lower-right images). Scale 
bar shows 25 nm. 
 Negative-stain: 6 µL of sample at a concen-
tration of a few nM was deposited on glow-
discharged copper grids (400-mesh) that previously 
had been coated with Parlodion and carbon. After 1 
min, the grids were blotted and stained with 6 µL of 
2% uranyl acetate for 1 min followed by blotting and 
storage in a desiccator overnight. 
doi: 10.1021/jacs.5b03770 
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 Positive stain: Inevitably, some regions of a 
negative-stained TEM grid exhibit positive staining. 
In these regions stain penetrates the sample parti-
cles, rather than coating them. We have found that 
certain structural features are sometimes better re-
solved through positive staining – in this case, the 
RNA-DNA hybrid appendage was more visible in 
positive-stained regions (Fig. S1). 
 
 10 µL of sample was mixed with 3 µL of glyc-
erol and loaded into a 1% agarose gel in virus elec-
trophoresis buffer (0.1 M sodium acetate, 1 mM 
EDTA, pH 5.5). The samples were electrophoresed at 
4°C at 50 V for 1 h and visualized with a FX Pro Plus 
Fluorimager/PhosphorImager (Bio-Rad) by exciting 
the UTP-AF488 of the B1 RNA and 6-FAM of the 
poly-T15, separately, and measuring the emitted fluo-
rescence intensity. The emission intensity of UTP-
AF488 (RNA) is shown in red, and that of 6-FAM 
(poly-T) is shown in green. 
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